GSVA results showed that down‐regulated genes of Tregs in tumour‐invaded TDLN versus PT were enriched in negatively regulating IL‐18 production, which is an important factor augmenting anti‐cancer immunity (Figure S7G).53 This evidence concerns the gene IL18 and cancer.